SCHEMBL563512

SCHEMBL563512

CCOC(=O)c1cc(C2(c3ccc(OCCOCCOCCOC)c(C(=O)OCC)c3)c3cc(Br)ccc3-c3ccc(Br)cc32)ccc1OCCOCCOCCOC

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.37
KMT2A Q03164 4/20 0.36
MEN1 O00255 3/20 0.36
ALDH1A1 P00352 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
KDM4E B2RXH2 4/20 0.35
GABRA1 P14867 1/20 0.35
GABRB1 P18505 1/20 0.35
GABRA3 P34903 1/20 0.35
GABRB2 P47870 1/20 0.35
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
MAPT P10636 4/20 0.34
LMNA P02545 3/20 0.34
PDE3B Q13370 1/20 0.34
PDE3A Q14432 1/20 0.34
ESR1 P03372 1/20 0.34
SMAD3 P84022 1/20 0.34
MAPK1 P28482 2/20 0.33
POLB P06746 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10322006 1.00 HTT (0.37) HTTKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL17807618 0.94 HTT (0.35) HTTKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL19996767 0.92 HTT (0.33) HTTKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL18506630 0.92 HTT (0.33) HTTKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL14929237 0.91 HTT (0.37) HTTKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL10111239 0.91 TSHR (0.32) HTTKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL10348623 0.89 TSHR (0.31) HTTKMT2AMEN1RAB9APDE3B
SCHEMBL11933648 0.89 LMNA (0.32) HTTKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL10348654 0.89 LMNA (0.32) HTTKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL15430909 0.87 HTT (0.38) HTTKMT2AMEN1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2597932-B1 MANUFACTURING METHOD FOR ORGANIC LIGHT-EMITTING DEVICE SUMITOMO CHEMICAL CO (JP) 2021-04-14 EP disclosed
EP-2680672-B1 METHOD FOR PRODUCING ORGANIC ELECTROLUMINESCENT ELEMENT SUMITOMO CHEMICAL CO (JP) 2021-03-31 EP disclosed
EP-3037398-B1 METHOD FOR MANUFACTURING CHEMICAL COMPOUND SUMITOMO CHEMICAL CO (JP) 2021-03-10 EP disclosed
EP-2485289-B1 LAMINATED STRUCTURE, POLYMER, ELECTROLUMINESCENT ELEMENT, AND PHOTOELECTRIC CONVERSION ELEMENT SUMITOMO CHEMICAL CO (JP) 2021-03-03 EP disclosed
EP-2605621-B1 ORGANIC ELECTROLUMINESCENT ELEMENT AND METHOD OF PRODUCING SAME SUMITOMO CHEMICAL CO (JP) 2020-07-15 EP disclosed
EP-2418033-B1 METAL COMPLEX AND COMPOSITION CONTAINING SAME SUMITOMO CHEMICAL CO (JP) 2020-05-06 EP disclosed
EP-2692796-B1 COMPOSITION SUMITOMO CHEMICAL CO (JP) 2019-07-10 EP disclosed
EP-2597933-B1 MANUFACTURING METHOD FOR ORGANIC ELECTROLUMINESCENCE ELEMENT SUMITOMO CHEMICAL CO (JP) 2019-06-12 EP disclosed
EP-2687304-B1 METAL COMPLEX COMPOSITIONS AND MIXTURE THEREOF SUMITOMO CHEMICAL CO (JP) 2019-01-23 EP disclosed
US-9982087-B2 Method for producing compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-05-29 US disclosed
US-20130134410-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND METHOD FOR MANUFACTURING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-05-30 US disclosed
EP-2597932-A1 MANUFACTURING METHOD FOR ORGANIC LIGHT-EMITTING DEVICE, AND ORGANIC LIGHT-EMITTING DEVICE Sumitomo Chemical Company, Limited (JP) 2013-05-29 EP disclosed
EP-2597696-A1 ORGANIC EL ELEMENT Sumitomo Chemical Company Limited (JP) 2013-05-29 EP disclosed
EP-2597934-A1 METHOD FOR PRODUCING ORGANIC EL ELEMENT Sumitomo Chemical Company, Limited (JP) 2013-05-29 EP disclosed
EP-2597933-A1 MANUFACTURING METHOD FOR ORGANIC ELECTROLUMINESCENCE ELEMENT Sumitomo Chemical Company, Limited (JP) 2013-05-29 EP disclosed
US-20130122625-A1 METHOD FOR MANUFACTURING ORGANIC ELECTROLUMINESCENT ELEMENT SUMITOMO CHEMICAL CO., LTD. (JP) 2013-05-16 US disclosed
US-20130112966-A1 METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE AND ORGANIC LIGHT-EMITTING DEVICE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-05-09 US disclosed
EP-2485289-A1 LAMINATED STRUCTURE, POLYMER, ELECTROLUMINESCENT ELEMENT, AND PHOTOELECTRIC CONVERSION ELEMENT Sumitomo Chemical Co., Ltd (JP) 2012-08-08 EP disclosed
US-20120181529-A1 LAYERED STRUCTURE, POLYMER, ELECTROLUMINESCENT DEVICE, AND PHOTOELECTRIC CONVERSION DEVICE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-07-19 US disclosed
US-20120032121-A1 METALLIC COMPOSITE AND COMPOSITION THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120032121-A1 METALLIC COMPOSITE AND COMPOSITION THEREOF CDH1, EPCAM, CD4 HTT 3725/4885KMT2A 2260/4885MEN1 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.